Results 171 to 180 of about 1,341,613 (310)

Knowledge Gaps, Treatment Preferences, and Unmet Clinical Needs Among Patients With Inflammatory Bowel Disease: A Cross‐Sectional Study

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study utilized a cross‐sectional survey via a structured questionnaire to evaluate disease‐related knowledge, treatment preferences, and unmet needs among 200 adults with confirmed inflammatory bowel disease (IBD) at a tertiary referral center.
Yi‐Chen Wu   +11 more
wiley   +1 more source

CDC Spotlight on Sexually Transmitted Infections & Prevention : West Virginia [PDF]

open access: yes
Rates of HIV, sexually transmitted infections (STIs), viral hepatitis, and substance use are rising across the US.STIs like chlamydia, gonorrhea, and syphilis can increase the risk of HIV infections \u2013 6% of sexually-acquired HIV infections are ...

core  

From Disability to Diagnosis: Baseline Findings from the Calgary Functional Movement Disorder Registry

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Functional movement disorder (FMD), a subtype of functional neurological disorder, is a complex neuropsychiatric syndrome characterized by inconsistent and incongruent motor symptoms. Despite its relatively high prevalence, FMD remains associated with delayed diagnosis, significant disability, and limited evidence to guide ...
Andrea Soumbasis   +6 more
wiley   +1 more source

CDC Spotlight on Sexually Transmitted Infections & Prevention : Alabama [PDF]

open access: yes
Rates of HIV, sexually transmitted infections (STIs), viral hepatitis, and substance use are rising across the US.STIs like chlamydia, gonorrhea, and syphilis can increase the risk of HIV infections \u2013 6% of sexually-acquired HIV infections are ...

core  

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Continuous subcutaneous foslevodopa/foscarbidopa (LDp/CDp) provides 24‐h delivery of levodopa‐carbidopa prodrugs for advanced Parkinson's disease. Real‐world 1‐year European data remain limited. Objectives To characterize 1‐year changes in motor, non‐motor, autonomic, quality‐of‐life and sleep outcomes, and in concomitant therapy ...
Mario Hero   +5 more
wiley   +1 more source

Gonococcal Tysonitis

open access: yesActas Dermo-Sifiliográficas
S. Berenguer-Ruiz   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy